Results 191 to 200 of about 55,496 (259)

Selective vulnerability of GABAergic neurons in chronic migraine. [PDF]

J Headache Pain
Hossain KH, Chuong T, Abad E, Lin J, Xia C, Li M, Chen Y, Arakaki X, Vasudevan A.   +8 more
europepmc   +1 more source

Opioid use, disability, and patient‐reported cognitive impairment in migraine: Multi‐country results from the Chronic Migraine Epidemiology and Outcomes—International Study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Opioids are widely used to treat migraine despite being contrary to clinical guidelines. In the Chronic Migraine Epidemiology and Outcomes–International (CaMEO‐I) Study, a large, international survey of people with migraine, opioid users were more likely than nonusers to experience moderate or severe migraine‐related disability ...
Elizabeth Leroux, Dawn C. Buse, Michel Lanteri‐Minet, Fumihiko Sakai, Manjit Matharu, Zaza Katsarava, Kristina M. Fanning, Karen Carr, Nicole Naccara, Janette Contreras‐De Lama, Richard B. Lipton   +10 more
wiley   +1 more source

The mechanism of different microglial receptors mediating central inflammation in chronic migraine: a meta-analysis. [PDF]

J Headache Pain
Lin X, Yu W, Lou J, Cao Z, Song W.
europepmc   +1 more source

Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. Background Galcanezumab is a calcitonin gene‐related peptide‐inhibiting monoclonal antibody indicated for the preventive treatment of migraine.
Irene Boz, Jan Lewis Brandes, Christopher Robinson, Maria Fernanda Scantamburlo Fernandes, Sarah Lipsius, LaRonda Morford, Enemona Emmanuel Adaji, Anaclara Prada Jardim, Holland C. Detke   +8 more
wiley   +1 more source

Impaired glymphatic function and advanced brain age gap in chronic migraine: a multimodal MRI study. [PDF]

J Headache Pain
Dai C, Fu F, Guo Y, Liu X, Tao Z, Zhang X, Li X, Lin C, Ye M, Huang M, Hu Y, Liu K, Cao Y, Chen K, Hu B, Liu X, Li Y.   +16 more
europepmc   +1 more source

The MIND study: Design, feasibility, and baseline characteristics of a smartphone‐based migraine cohort

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Our objective was to describe the design, feasibility, and baseline characteristics of the Migraine Impact on Neurocognitive Dynamics study, a 30‐day smartphone‐based, prospective, decentralized, observational cohort study evaluating high‐frequency assessment of cognition and symptoms in adults with migraine.
Babak Khorsand, Devin Teichrow, Richard B. Lipton, Ali Ezzati   +3 more
wiley   +1 more source

Kappa opioid receptor availability correlates with depressive symptom burden in chronic migraine: a preliminary investigation. [PDF]

J Headache Pain
Kim DJ, Saberi M, Kaur T, Shao X, Koeppe RA, Scott PJH, Porreca F, DaSilva AF.   +7 more
europepmc   +1 more source

Longitudinal effects of CGRP‐targeting migraine therapies on blood pressure and body mass index: A 12‐month retrospective analysis

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To compare blood pressure (BP) and body mass index (BMI) trajectories associated with individual calcitonin gene‐related peptide (CGRP)‐targeting migraine therapies versus matched CGRP‐unexposed controls. Background CGRP is a potent vasodilator with established roles in vascular homeostasis and metabolic regulation.
Phillip Phan, Scott Keith, Michael Li, Richard Hass, Wan‐Jen Hsieh, Michael Marmura, Hsiangkuo Yuan   +6 more
wiley   +1 more source

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience. [PDF]

Toxins (Basel)
Silvestro M, Albanese M, Orologio I, Iannone LF, Pistoia F, Battistini S, Avino G, Petracca M, Romozzi M, Ornello R, Centonze D, Sacco S, Russo A, On Behalf Of The Italian Headache Registry RICe Study Group.   +13 more
europepmc   +1 more source

Real‐world diagnosis and treatment of individuals with migraine in the United States: The Migraine Insights in Diagnosis and Treatment (MIND) study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The objective of this study was to describe the real‐world diagnosis and treatment patterns of individuals newly diagnosed with migraine in the United States (US). Background Over 10% of adults in the US are living with migraine.
Fred Cohen, Vincent Martin, Avani Patel, Shelby L. Corman, Katie B. Tellor, Meghan Fajardo, D. Cortney Hayflinger, Simon Dagenais   +7 more
wiley   +1 more source